Meeting
2023 ASCO Annual Meeting
First results from the RETgistry: A global consortium for the study of resistance to RET inhibition in RET-altered solid tumors.
Authors
Alissa Jamie Cooper
Massachusetts General Hospital, Boston, MA
Alissa Jamie Cooper , Alexander E. Drilon , Julia K. Rotow , Stephen V. Liu , Oliver Gautschi , Katherine Emilie Rhoades Smith , Dae Ho Lee , Misako Nagasaka , Herbert H. F. Loong , Nathan A. Pennell , Jyoti D. Patel , Martin Früh , Benjamin J. Solomon , Georg Pall , Natalie F. Uy , Jonathan W. Riess , Lori J. Wirth , Beow Y. Yeap , Justin F. Gainor , Jessica Jiyeong Lin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 9065)
DOI
10.1200/JCO.2023.41.16_suppl.9065
Abstract #
9065
Poster Bd #
53
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Multiplexed genetic analysis of malignant pleural mesothelioma and the relationship to clinical outcome.
First Author: Takehito Shukuya
Poster
2022 ASCO Annual Meeting
Molecular characterization of NF1-mutated NSCLC and clinical outcomes.
First Author: Christopher Gates
Poster
2016 ASCO Annual Meeting
Genetic heterogeneity of KRAS-mutated NSCLC: Co-occurrence of potentially targetable aberrations and evolutionary background.
First Author: Matthias Scheffler
Poster
2016 ASCO Annual Meeting
Development of nationwide genomic screening project (LC-SCRUM-Japan) contributing to the establishment of precision medicine in Japan.
First Author: Takuma Yokoyama